Menu Close

BCAAs for patients with hepatic encephalopathy


Branched-chain amino acids for patients with hepatic encephalopathy

This review found that branched-chain amino acids (AACR) were associated with a beneficial effect on cirrhosis-associated hepatic encephalopathy. Evidence suggested that BCAAs should be considered in the treatment of people with hepatic encephalopathy.. Adverse events were not serious and included mainly gastrointestinal symptoms.. There was no evidence to support or refute an effect of BCAAs on mortality., quality of life or nutritional outcomes.

Branched-chain amino acids are neuroprotective against traumatic brain injury and improve recovery rate: prophylactic role for contact sports and emergent use

Read the entire article (English)

share it!

Salufarm. Clinical nutrition.

Restricted access area exclusively for healthcare professionals.
The information you are about to view is targeted, Therefore, specific training in this area is necessary for a correct interpretation of the contents.. If you don't have the above requirements, cannot access this area.

I declare that I am a healthcare professional.